Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A clinical study launching next month at Mount Sinai is like the search for the Holy Grail.
And Dr. Ravi Retnakaran, who sees it as just that, is leading the way.
Researchers are launching a study that could halt type-2 diabetes in its early stages and effectively alter how the disease is treated.
Data collected from patient studies by Retnakaran and Dr. Caroline Kramer found short-term insulin therapy for two or three weeks can restore the body?s ability to make and use insulin.
?After you stop your short-term therapy then the body can take over,? he said. ?You?re resetting the beta cells.?
http://www.thestar.com/news/gta/201...ng_a_haircut_mount_sinai_researchers_say.html
And Dr. Ravi Retnakaran, who sees it as just that, is leading the way.
Researchers are launching a study that could halt type-2 diabetes in its early stages and effectively alter how the disease is treated.
Data collected from patient studies by Retnakaran and Dr. Caroline Kramer found short-term insulin therapy for two or three weeks can restore the body?s ability to make and use insulin.
?After you stop your short-term therapy then the body can take over,? he said. ?You?re resetting the beta cells.?
http://www.thestar.com/news/gta/201...ng_a_haircut_mount_sinai_researchers_say.html